Prolastin: Clinical Trials

3 trials of Prolastin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1
Phase 22Completed 1, Terminated 1

Follow Prolastin: new trials by email Literature Review of Prolastin trials Research Report on Prolastin

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease
α1 Proteinase Inhibitor, Placebos - HIV Disease
Phase 2 / Phase 3TerminatedInstitute for Human Genetics and Biochemistry122012-04-012020-08-31
Therapy to Elevate CD4 Counts in HIV-1 Disease
alpha-1-Proteinase Inhibitor - HIV Disease
Phase 2 / Phase 3CompletedInstitute for Human Genetics and Biochemistry42006-12-012021-09-28
The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency
alpha-1 proteinase inhibitor (human) - Alpha 1-Antitrypsin Deficiency
Phase 3CompletedGrifols Therapeutics LLC382006-06-012014-08-19

Conditions studied

Acquired Immunodeficiency Syndrome (2)  ·  Pulmonary Emphysema (1)  ·  alpha 1-Antitrypsin Deficiency (1)

Sponsors

Institute for Human Genetics and Biochemistry (2)  ·  Grifols Therapeutics LLC (1)

Countries

United States (3)  ·  United Kingdom (1)

Top investigators

Cynthia Bristow, PhD (1)  ·  Cynthia L Bristow, PhD (1)  ·  Jose Cortes, MD (1)  ·  Kim Hanna, MSc (1)

Results publications

PMID 31824943, PMID 24229737